Global Immunology Market to Rise Impressively at 8.1%; Increasing Product Approvals to Favor Market Growth

1

• Global Immunology Market to Rise Impressively at
  8.1 Increasing Product Approvals to Favor
  Market Growth
• Immunology Market summarized details by key
  Disease Indication Rheumatoid Arthritis,
  Psoriatic Arthritis, Plaque Psoriasis, Ankylosing
  Spondylitis, Inflammatory Bowel Disease,
  Prophylaxis of Organ Rejection and more
• The Global Immunology Market is likely to expand
  in the coming years driven by the high
  prevalence of immunological disorders, resulting
  from environmental factors. According to a
  report published by Fortune Business Insights,
  titled IMMUNOLOGY GLOBAL MARKET ANALYSIS,
  INSIGHTS AND FORECAST, 2019-2026, the market was
  valued at US 77,365.4 Mn in 2018. Fortune
  Business Insights has predicted that the market
  will reach US 143,833.2 Mn by 2026 and will
  exhibit a CAGR of 8.1.
• Browse Complete Report Details at
  https//www.fortunebusinessinsights.com/industry-
  reports/immunology-market-100657
• Some of the major companies that are present in
  the Global Immunology Market are
• AbbVie Inc.
• Janssen Global Services, LLC (Johnson Johnson)
• F. Hoffmann-La Roche Ltd
• Amgen Inc.
• Pfizer Inc.
• Novartis AG
• Astellas
• Bristol-Myers Squibb Company
• Merck Sharp Dohme Corp.
• UCB SA
• ALLERGAN
• Other Prominent Players
• The global immunology market is likely to expand
  in the coming years driven by the high demand
  for immunology drugs resulting from the high
  prevalence of immunological disorders. The
  severity of immunological disorders has created
  an increasing awareness around the world.
  Various initiatives and advisory programs have
  been conducted by the government as well as
  public organizations. This, in turn, will fuel
  the demand for immunology drugs. Furthermore, the
  increased efficiency of immunology drugs has
  contributed to better patient outcomes, which in
  turn has led to subsequent growth of the global
  immunology market.

2
The spate of recent regulatory approvals for the
immunology products is anticipated to contribute
to the overall positive growth of the market. For
instance, the recent regulatory approval and the
subsequent launch of TREMFYA (Guselkumab) by
Janssen Global Services, LLC (Johnson
Johnson), is expected to lead to better outcome
for the patients. TREMFYA (Guselkumab) was
launched for the treatment of moderate to severe
plaque psoriasis, a seriously debilitating
immunological disorder. TREMFYA is the only
biologic approved for the treatment of moderate
to severe plaque psoriasis, that selectively
blocks the interleukin (IL)-23, leading to a
vast improvement in the symptoms of the patient.
Apart from being one of the emerging drugs of
the immunology market, Fortune Business Insights
predicts that Janssen Global Services, LLC
(Johnson Johnson) latest product offering will
have a positive impact on the global immunology
market in the forthcoming years. AbbVie Gains FDA
Approval of SKYRIZI Product to Witness High
Demand in No Time The global immunology market
has gained impetus from the availability of
several regulatory approved drugs. The approval
of new drugs and the trends of improvements in
clinical efficiencies will bode well for the
global immunology market. In 2019, AbbVie
received approval from the Food and Drug
Administration (FDA) for the usage of SKYRIZI.
The drug was aimed at the treatment of moderate
to severe plaque psoriasis. This drug was
inclined towards the treatment of adults
diagnosed with psoriasis and have been
recommended for or undergoing therapy. The drug
is likely to gain huge popularity among
healthcare professionals and its high clinical
efficacy will fuel the demand in the coming
years. Besides product launches and drug
approvals, Fortune Business Insights assesses
several other factors that have made significant
growth contributions to the global immunology
market. Companies are encouraged by the growing
usage approvals by regulatory authorities across
the world. Several company mergers and
acquisitions have also accounted for growth of
the global immunology market. Some of the
leading companies that are operating in the
global immunology market are AbbVie Inc.,
Janssen Global Services, LLC (Johnson Johnson),
F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer
Inc, Novartis AG, Astellas, Bristol-Myers Squibb
Company, Merck Sharp Dohme Corp., UCB SA, and
ALLERGAN. Speak To Analyst at https//www.fortuneb
usinessinsights.com/enquiry/speak-to-
analyst/immunology-market-100657 About
Us Fortune Business Insights offers expert
corporate analysis and accurate data, helping
organizations of all sizes make timely decisions.
We tailor innovative solutions for our clients,
assisting them address challenges distinct to
their businesses. Our goal is to empower our
clients with holistic market intelligence,
giving a granular overview of the market they are
operating in.
3
Our reports contain a unique mix of tangible
insights and qualitative analysis to help
companies achieve sustainable growth. Our team
of experienced analysts and consultants use
industry- leading research tools and techniques
to compile comprehensive market studies,
interspersed with relevant data. At Fortune
Business Insights we aim at highlighting the most
lucrative growth opportunities for our clients.
We therefore offer recommendations, making it
easier for them to navigate through
technological and market-related changes. Our
consulting services are designed to help
organizations identify hidden opportunities and
understand prevailing competitive challenges.